<p>The therapeutic dose of lithium (Li) compounds, which
are widely used for the treatment of psychiatric and hematologic disorders, is
close to its toxic level; therefore, drug monitoring protocols are mandatory. Herein,
we propose a fast, simple, and low-cost analytical procedure for the traceable determination
of Li concentration in human serum, based on the monitoring of the Li isotope dilution
through the partially resolved isotope shift in its electronic transition
around 670.80 nm using a commercially available high-resolution continuum
source graphite furnace atomic absorption spectrometer. With this technique, serum
samples only require acidic digestion before analysis. The procedure requires
three measurements—an enriched <sup>6</sup>Li spike, a mixture of a certified
standard solution and spike, and a mixture of the sample and spike with a
nominal <sup>7</sup>Li/<sup>6</sup>Li ratio of 0.82. Lanthanum has been used as
an internal spectral standard for wavelength correction. The spectra are
described as the linear superposition of the contributions of the respective
isotopes, each consisting of a spin-orbit doublet, which can be expressed as
Gaussian components with constant spectral position and width and different
relative intensity, reflecting the isotope ratio in the sample. Both, the
spectral constants and the correlation between isotope ratio and relative band
intensity have been experimentally obtained using commercially available materials
enriched with Li isotopes. The procedure has been validated using five human
serum certified reference materials. The results are metrologically comparable and compatible
to the certified values. The measurement uncertainties are comparable to those
obtained by the more complex and expensive technique, isotope dilution mass
spectrometry. </p>